Malignant Skin Neoplasm — Trials

Malignant Skin Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,248 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 320
Recruiting: 171
Ph III recruiting: 11
Growth YoY: +11.1%
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (202)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06647342	The Effect of Reduced Bleomycin in Electrochemotherapy Treatment(BLESS)	recruiting	Phase 4	55	Julie GehlOTHER	1	Sep 15, 2026	clinicaltrials
NCT07426484	Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy	recruiting	Phase 4	80	Dana-Farber Cancer InstituteOTHER	1	Aug 11, 2026	clinicaltrials